It doesn't make sense that ilns would keep on agreeing to these delays it started 2 yrs ago why not just take it to trial also Pfizer has a pretty good idea by now if ponezumab is going to work why would they keep to trials ongoing and risk a big settlement
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.